Institut für Experimentelle und Klinische Pharmakologie und Toxikologie

Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die nicht zum Universitätsklinikum Erlangen gehören
close-button

Project Types

Third Party Funds Group - Overall project
Third Party Funds Group - Sub project
Third party funded individual grant
Internally funded project
FAU own research funding: EFI / IZKF / EAM ...
Non-FAU Project

Status

Project year

From
To
J115: Conjugated steroids in plasma and urine as diagnostic and prognostic biomarkers for adrenocortical carcinoma Aug. 1, 2024 - Jan. 31, 2027 D037: ACLY as a therapeutic target to promote T cell-driven antitumor immune response in IBD-associated colon cancer April 1, 2023 - Sept. 30, 2025 D042: Role of prosaposin (PSAP) in liver steatosis-triggered hepatocellular carcinoma April 1, 2023 - Sept. 30, 2025 P139: Modulation of Pain Perception by 3-Indolepropionic Acid in Arthritis: Implications for the Clinical Course June 16, 2024 - May 15, 2025 P134: Untargeted metabolomics in adrenal tumors: Screening for novel diagnostic biomarkers in urine Aug. 1, 2023 - July 31, 2024 P080: Impact of microbial tryptophan metabolites on intestinal permeability and rheumatoid arthritis June 1, 2021 - May 31, 2022